Jump to contentUniversity of Michigan Health System - link
Department of Internal Medicine - link

SCLERODERMA PROGRAM
Division of Rheumatology

search this site
 

About Us
Current News

News Archive
Support Our Work
How to Schedule an Appointment
Contact Us



Faculty




Research




Friends & Supporters




FOR PATENTS
Learn About Scleroderma



For Health Care Professionals




Related Programs




Related Links




Internal Resources




Internal Medicine Divisions




Scleroderma Home


 
About Us

 

The University of Michigan Scleroderma Program was organized in 2004 in the Division of Rheumatology, Department of Internal Medicine at the University of Michigan Medical School.

Scleroderma is an inherently complex disease which is best addressed by a multidisciplinary team approach to treatment and research. The University of Michigan Medical School is one of the leading research institutions in the world. Its clinical and scientific assets are extensive, cutting edge and uniquely suited to the needs of the scleroderma community.

The goals of the Scleroderma Program are to develop effective therapies for scleroderma and its complications and to research the causes and mechanisms of disease. It is only through enhanced understanding of disease process that a cure will be possible.

Based in the Division of Rheumatology, faculty from many disciplines, including Pulmonary Medicine, the Pulmonary Hypertension Program of the Division of Cardiology, Pediatric Rheumatology, the Department of Dermatology, the Division of Hand Surgery, the Department of Occupational Therapy; and the University of Michigan Cancer Center, currently participate in Program activities.

The Scleroderma Program provides clinical care, primarily on a consultative basis to patients from Michigan and the Midwest, but also serves as an international referral ce

performance of complex trials designed to improve the quality of life and extend survival. Crucial to this enterprise is refined investigation of the science of outcome measures, which in turn, leads to more robustly designed clinical trials for the future. An effective and talented team has been assembled and a broad portfolio of research is in progress.

Increasing focus is on initiatives in research into the cause and pathobiology of scleroderma. Basic scientists are active at the University of Michigan in areas of direct relevance to scleroderma including the biology of fibrosis, vascular biology, and basic cellular immunology.

The Scleroderma Program at the University of Michigan is dedicated to advancing research and improving care for patients with scleroderma and related diseases.

Back to About Us - Top of Page

 

 
   
   

U-M Medical School
| Hospitals & Health Centers | U-M | TEXT-ONLY

University of Michigan Health System
1500 E. Medical Center Drive  Ann Arbor, MI 48109   734-936-4000
(c) copyright Regents of the University of Michigan
Template developed & maintained by: Public Relations & Marketing Communications
Contact UMHS

 
The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site.
Complete disclaimer and Privacy Statement

UMHS HOME

Health Topics A-Z

For Patients & Families

For Health Professionals

Search Tools & Index